The development and implementation of a “B-Team” (buprenorphine team) to treat hospitalized patients with opioid use disorder

IF 2 4区医学 Q3 HEALTH POLICY & SERVICES

Healthcare-The Journal of Delivery Science and Innovation Pub Date : 2021-12-01 DOI:10.1016/j.hjdsi.2021.100579

Richard Bottner , Jillian B. Harvey , Amber N. Baysinger , Kirsten Mason , Snehal Patel , Alanna Boulton , Nicholaus Christian , Blair Walker , Christopher Moriates

{"title":"The development and implementation of a “B-Team” (buprenorphine team) to treat hospitalized patients with opioid use disorder","authors":"Richard Bottner , Jillian B. Harvey , Amber N. Baysinger , Kirsten Mason , Snehal Patel , Alanna Boulton , Nicholaus Christian , Blair Walker , Christopher Moriates","doi":"10.1016/j.hjdsi.2021.100579","DOIUrl":null,"url":null,"abstract":"<div><h3>Implementation insights</h3><ul><li>•Hospitalization is a reachable moment to address opioid and other substance use disorders. This includes initiation of pharmacotherapy such as buprenorphine, which is the standard of care but not frequently offered.</li><li>•Initiating pharmacotherapy for interested patients with opioid use disorder (OUD) during hospitalization does not require a formal addiction consultation service and can be accomplished by any in-hospital prescriber, aided by interprofessional and multidisciplinary teams with support from senior leadership.</li><li>•Barriers to widespread adoption include lack of education; stigma towards people with substance use disorders; inadequate outpatient capacity to address OUD; regulatory requirements; and challenges to modifying electronic health record algorithms, clinical workflows, and institutional policies.</li></ul></div>","PeriodicalId":29963,"journal":{"name":"Healthcare-The Journal of Delivery Science and Innovation","volume":"9 4","pages":"Article 100579"},"PeriodicalIF":2.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213076421000622/pdfft?md5=f013111320633d43999368bb4ca70c62&pid=1-s2.0-S2213076421000622-main.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare-The Journal of Delivery Science and Innovation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213076421000622","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 4

Abstract

Implementation insights

•
Hospitalization is a reachable moment to address opioid and other substance use disorders. This includes initiation of pharmacotherapy such as buprenorphine, which is the standard of care but not frequently offered.
•
Initiating pharmacotherapy for interested patients with opioid use disorder (OUD) during hospitalization does not require a formal addiction consultation service and can be accomplished by any in-hospital prescriber, aided by interprofessional and multidisciplinary teams with support from senior leadership.
•
Barriers to widespread adoption include lack of education; stigma towards people with substance use disorders; inadequate outpatient capacity to address OUD; regulatory requirements; and challenges to modifying electronic health record algorithms, clinical workflows, and institutional policies.

查看原文本刊更多论文

建立和实施“b组”(丁丙诺啡组)治疗住院阿片类药物使用障碍患者

•住院是解决阿片类药物和其他物质使用障碍的一个可触及的时刻。这包括开始药物治疗，如丁丙诺啡，这是标准的护理，但不经常提供。•在住院期间，对有兴趣的阿片类药物使用障碍(OUD)患者启动药物治疗不需要正式的成瘾咨询服务，可由任何住院开处方者在高级领导的支持下，在跨专业和多学科团队的协助下完成。•广泛采用的障碍包括缺乏教育;对物质使用障碍患者的污名;治疗OUD的门诊能力不足;监管要求;以及修改电子健康记录算法、临床工作流程和机构政策的挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Healthcare-The Journal of Delivery Science and Innovation HEALTH POLICY & SERVICES-

CiteScore

4.90

自引率

0.00%

发文量

期刊介绍： HealthCare: The Journal of Delivery Science and Innovation is a quarterly journal. The journal promotes cutting edge research on innovation in healthcare delivery, including improvements in systems, processes, management, and applied information technology. The journal welcomes submissions of original research articles, case studies capturing "policy to practice" or "implementation of best practices", commentaries, and critical reviews of relevant novel programs and products. The scope of the journal includes topics directly related to delivering healthcare, such as: ● Care redesign ● Applied health IT ● Payment innovation ● Managerial innovation ● Quality improvement (QI) research ● New training and education models ● Comparative delivery innovation